The Dip That Keeps On Dipping: 2 Strong Buy Stocks Near 52-Week Lows With 50%+ Upside PotentialSeeking Alpha • 05/19/26
ABT vs. ZBH: Which Surgical Equipment Stock Is the Better Bet Now?Zacks Investment Research • 05/18/26
Abbott Stock at 52-Week Low After Q1 Earnings: Book Profits or Hold?Zacks Investment Research • 05/13/26
Abbott's Medical Device Strategy Supports Long-Term Growth OutlookZacks Investment Research • 05/08/26
Got $5,000? These 3 High-Yielding Stocks Are Trading Near Their 52-Week LowsThe Motley Fool • 05/06/26
Abbott receives FDA clearance and CE Mark for next-generation Ultreon™ 3.0 AI-powered coronary imaging platformPRNewsWire • 04/28/26
Abbott showcases strength of its technologies to address abnormal heart rhythms with late-breaking clinical data at Heart Rhythm Society 2026PRNewsWire • 04/25/26
Abbott Laboratories Just Got Interesting: Dividend Yield Near 3% Signals OpportunitySeeking Alpha • 04/21/26
Wall Street Refuses to Blink: 2 Healthcare Stocks at 52-Week Lows That Analysts Still Love24/7 Wall Street • 04/21/26
Is the Options Market Predicting a Spike in Abbott Laboratories Stock?Zacks Investment Research • 04/21/26